Four-week supplementation with a natural dietary compound produces favorable changes in body composition.
The purpose of this study was to determine whether a natural dietary supplement produced favorable changes in body composition during a 4-week diet- and-exercise program. The active compound contains a patented combination of chromium picolinate, inulin, capsicum, L-phenylalanine, and other lipotropic nutrients. A double-blind, weight-loss intervention design was used. Participants were randomly assigned to either a diet/exercise/supplement group (n = 56) or a diet/exercise/placebo group (n = 67). Caloric intake was reduced to 1500 kcal/d and participants walked for 45 minutes, 5 days a week, to attain between 60% and 80% of predicted maximal heart rate. Analysis of covariance (ANCOVA) showed significant differences (P < .05) between groups in percent body fat, fat mass, and fat-free mass; no significant differences were found (P > .05) in body weight, body mass index, or energy intake. Independent t tests showed no significant differences (P > .05) in diet composition between groups. Results indicate that the addition of a natural dietary supplement during a 4-week diet-and-exercise weight-loss program accelerates the rate of body fat loss and helps maintain fat-free mass (lean tissue), thereby producing favorable changes in body composition.
Hoeger
W W
WW
Department of Physical Education, Boise State University, ID 83725, USA.
Harris
C
C
Long
E M
EM
Hopkins
D R
DR
D000273:Adipose Tissue / Q000378:metabolism; D000328:Adult; D000704:Analysis of Variance; D001823:Body Composition; D015992:Body Mass Index; D002212:Capsicum; D002794:Choline / Q000627:therapeutic use*; D019587:Dietary Supplements; D004311:Double-Blind Method; D004734:Energy Metabolism; D005260:Female; D006801:Humans; D007444:Inulin / Q000008:administration & dosage / Q000627:therapeutic use*; D007502:Iron Chelating Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000178:diet therapy* / Q000378:metabolism / Q000628:therapy; D010649:Phenylalanine / Q000008:administration & dosage; D010848:Picolinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D010946:Plants, Medicinal; D012016:Reference Values; D012885:Skinfold Thickness; D016896:Treatment Outcome; D017968:Vanadium Compounds / Q000627:therapeutic use*
C117484:Biotrol; D007502:Iron Chelating Agents; D010848:Picolinic Acids; D017968:Vanadium Compounds; D010649:Phenylalanine; D007444:Inulin; D002794:Choline; C030614:picolinic acid